Cypress Capital Advisors, LLC Amgen Inc Transaction History
Cypress Capital Advisors, LLC
- $160 Billion
- Q2 2025
A detailed history of Cypress Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cypress Capital Advisors, LLC holds 3,416 shares of AMGN stock, worth $991,084. This represents 0.6% of its overall portfolio holdings.
Number of Shares
3,416
Previous 3,382
1.01%
Holding current value
$991,084
Previous $1.05 Billion
9.48%
% of portfolio
0.6%
Previous 0.73%
Shares
3 transactions
Others Institutions Holding AMGN
# of Institutions
3,278Shares Held
442MCall Options Held
6.15MPut Options Held
7.25M-
Vanguard Group Inc Valley Forge, PA53.7MShares$15.6 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.4 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.52 Billion0.32% of portfolio
-
Capital International Investors Los Angeles, CA18.9MShares$5.49 Billion0.95% of portfolio
-
Capital World Investors Los Angeles, CA16.9MShares$4.89 Billion0.71% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $155B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...